Dennis Slamon - Mar 18, 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Mar 18, 2024
Transactions value $
-$33
Form type
4
Date filed
3/20/2024, 05:13 PM
Previous filing
May 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $797K +10K +32.46% $79.70 40.8K Mar 18, 2024 Direct
transaction BMRN Common Stock Tax liability -$797K -9.51K -23.3% $83.81 31.3K Mar 18, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Options Exercise $0 -10K -100% $0.00* 0 Mar 18, 2024 Common Stock 10K $79.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transaction from this specific stock option grant.